No Evidence of Alcohol Interaction with Ketamine Treatment for Depression
There is no evidence that consuming two beers within 24 hours before ketamine infusion for depression alters its antidepressant efficacy or increases adverse effects. The available guidelines, FDA labeling, and research literature do not address this specific interaction.
What the Evidence Actually Shows
FDA Label Guidance on Alcohol
The FDA label for ketamine warns about concomitant use with CNS depressants including alcohol, which may result in profound sedation, respiratory depression, coma, and death 1. However, this refers to simultaneous administration during the infusion period, not pre-treatment consumption 24 hours prior.
Clinical Trial Evidence
None of the major ketamine studies for depression specifically examined or reported on pre-treatment alcohol consumption:
- The 2022 VA/DoD guidelines 2 recommend ketamine for treatment-resistant depression but do not mention alcohol consumption timing
- Multiple RCTs and meta-analyses 3 excluded patients with active substance use issues but did not specify pre-treatment alcohol restrictions
- Recent studies 4, 5, 6 showing ketamine's rapid antidepressant effects (within 4-24 hours) did not report alcohol consumption as an exclusion criterion or confounding variable
Alcohol Use Disorder Comorbidity Data
Importantly, one 2025 RCT specifically studied ketamine in patients with comorbid MDD and active alcohol use disorder 7. This study found ketamine was safe and effective even in patients with ongoing heavy drinking (at least 4 times monthly), with no study-related serious adverse events. This suggests ketamine can be safely administered even in the context of regular alcohol use.
Clinical Reasoning
Why Two Beers 24 Hours Prior Is Unlikely to Matter
Pharmacokinetic considerations:
- Alcohol has a half-life of approximately 4-5 hours
- Two standard beers would be completely metabolized within 12-16 hours
- At 24 hours post-consumption, no alcohol would remain in the system
Pharmacodynamic considerations:
- The FDA warning about CNS depression refers to additive effects during concurrent use
- Ketamine's dissociative and cardiovascular effects occur during and immediately after infusion
- No evidence suggests alcohol consumed a day prior alters NMDA receptor function or ketamine metabolism
Common Pitfalls to Avoid
Do not confuse:
- Active intoxication during infusion (contraindicated) with prior consumption
- Chronic alcohol use disorder (which may require additional monitoring) with occasional consumption
- The need for medical supervision during ketamine infusion (always required 2) with pre-treatment restrictions
Practical Recommendation
Proceed with ketamine treatment as planned if the patient consumed two beers the day before. Ensure standard ketamine administration protocols are followed:
- Monitor vital signs closely during and for 2 hours post-infusion 2
- Assess for dissociative symptoms 8
- Watch for hemodynamic instability 1
- Ensure patient does not drive for 24 hours post-treatment 1
The only alcohol-related concern would be if the patient is intoxicated at the time of infusion or has severe alcohol use disorder requiring medical detoxification. Even in patients with active AUD, ketamine has been shown safe and effective 7.